Literature DB >> 11726084

Review: surgical shunts and encephalopathy.

J Klempnaue1, H Schrem.   

Abstract

Historically, surgical shunts have played an important role in the treatment of patients with portal hypertension associated with ascites and/or variceal esophageal bleeding. Today, in the era of liver transplantation most patients with end-stage liver disease and concomitant portal hypertension and associated problems are best treated by liver grafting. The successful introduction of transjugular intrahepatic portosystemic shunting (TIPS), performed by radiologists and gastroenterologists, provides a very effective alternative to surgical shunt procedures. One advantage of TIPS is that this procedure does not interfere with subsequent liver grafting. Today, surgical shunts have clearly lost ground to the less invasive TIPS procedure. Surgical shunts still maintain a role: as a salvage procedure in selected cases and in emergency situations. Surgical shunts are associated with a high rate of encephalopathy. In most cases selective surgical shunts should be preferred to nonselective surgical shunts. The role of partial surgical shunts versus selective surgical shunts remains to be determined. Hepatic encephalopathy is a common complication of all shunt procedures and is dependent on the shunt volume. Liver grafting is able to reverse encephalopathy because of a shunting procedure. In our institution, we prefer TIPS over surgical shunts as a bridging procedure before liver transplantation.

Entities:  

Mesh:

Year:  2001        PMID: 11726084     DOI: 10.1023/a:1011606326934

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  19 in total

Review 1.  The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Neurochem Int       Date:  2000-04       Impact factor: 3.921

Review 2.  Transjugular intrahepatic portosystemic shunts (TIPS): a decade later.

Authors:  J P Ong; M Sands; Z M Younossi
Journal:  J Clin Gastroenterol       Date:  2000-01       Impact factor: 3.062

Review 3.  Which portosystemic shunt is best?

Authors:  L F Rikkers; W T Sorrell; G Jin
Journal:  Gastroenterol Clin North Am       Date:  1992-03       Impact factor: 3.806

Review 4.  Variceal hemorrhage: surgical therapy.

Authors:  L F Rikkers; G Jin
Journal:  Gastroenterol Clin North Am       Date:  1993-12       Impact factor: 3.806

Review 5.  The treatment of oesophageal varices: a debate and a discussion.

Authors:  H O Conn; D Lebrec; J Terblanche
Journal:  J Intern Med       Date:  1997-02       Impact factor: 8.989

6.  Partial portal decompression for variceal hemorrhage.

Authors:  K Johansen
Journal:  Am J Surg       Date:  1989-05       Impact factor: 2.565

Review 7.  Current management of esophageal variceal bleeding.

Authors:  S J Knechtle; L F Rikkers
Journal:  Adv Surg       Date:  1999

Review 8.  Tryptophan metabolism and hepatic encephalopathy. Studies on the sedative properties of oxindole.

Authors:  G Mannaioni; R Carpenedo; R Corradetti; V Carlà; I Venturini; M Baraldi; M L Zeneroli; F Moroni
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

Review 9.  Narrow-diameter portacaval shunts for management of variceal bleeding.

Authors:  J C Collins; E B Rypins; I J Sarfeh
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

10.  Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life.

Authors:  B Langer; B R Taylor; D R Mackenzie; T Gilas; R M Stone; L Blendis
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

View more
  6 in total

1.  Medical and surgical management of portal hypertension in children.

Authors:  Riccardo A Superina; Estella M Alonso
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

2.  Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.

Authors:  Vanessa Stadlbauer; Josef Tauss; Horst R Portugaller; Philipp Stiegler; Florian Iberer; Rudolf E Stauber
Journal:  Metab Brain Dis       Date:  2006-12-14       Impact factor: 3.584

3.  Hepatic encephalopathy therapy: An overview.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

4.  Transjugular intrahepatic porto-systemic shunt and variceal embolisation in the management of bleeding stomal varices.

Authors:  Bassam Alkari; Nabeel M Shaath; Yesar El-Dhuwaib; Ali Aboutwerat; Thomas W Warnes; Nicholas Chalmers; Basil J Ammori
Journal:  Int J Colorectal Dis       Date:  2005-01-14       Impact factor: 2.571

5.  Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial.

Authors:  Lei Wang; Zhibo Xiao; Zhendong Yue; Hongwei Zhao; Zhenhua Fan; Mengfei Zhao; Fuliang He; Shan Dai; Bin Qiu; Jiannan Yao; Qiushi Lin; Xiaoqun Dong; Fuquan Liu
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

6.  Long-term results with the modified Sugiura procedure for the management of variceal bleeding: standing the test of time in the treatment of bleeding esophageal varices.

Authors:  D Voros; A Polydorou; G Polymeneas; I Vassiliou; A Melemeni; K Chondrogiannis; V Arapoglou; G P Fragulidis
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.